Specialized Medical Company (TADAWUL:4019)

Saudi Arabia · Delayed Price · Currency is SAR

18.31

-0.04 (-0.22%)

Apr 28, 2026, 3:15 PM AST

Market Cap	4.59B
Revenue (ttm)	1.54B
Net Income (ttm)	266.23M
Shares Out	250.00M
EPS (ttm)	1.06
PE Ratio	17.23
Forward PE	20.39
Dividend	1.12 (6.10%)
Ex-Dividend Date	May 18, 2026

Volume	215,565
Average Volume	496,988
Open	18.36
Previous Close	18.35
Day's Range	18.29 - 18.40
52-Week Range	17.30 - 25.00
Beta	n/a
RSI	46.26
Earnings Date	May 10, 2026

About TADAWUL:4019

Specialized Medical Company owns and operates hospitals, clinics, and medical centers in the Kingdom of Saudi Arabia. The company operates through Medical Services, and Pharmacies and Others segments. It provides diagnostic and therapeutic services for emergency medicine, cardiology, internal and family medicine, and pediatrics; and ancillary services, such as lab histopathology, diagnostic radiology and nuclear medicine, anesthesiology, pharmacy, and physiotherapy rehab. The company also operates surgical units comprising operating room and re... [Read more]

Industry Medical Care Facilities

Sector Healthcare

Founded 1994

Employees 3,353

Stock Exchange Saudi Stock Exchange

Ticker Symbol 4019

Full Company Profile

Financial Performance

In 2025, TADAWUL:4019's revenue was 1.54 billion, an increase of 7.00% compared to the previous year's 1.44 billion. Earnings were 266.23 million, an increase of 43.74%.

Financial Statements

News

Specialized Medical Company Earnings Call Transcript: Q4 2025

Strong revenue and profit growth in 2025 driven by acute and outpatient expansion, with a 43.7% rise in net profit and improved margins. Guidance for 2026 is conservative due to ramp-up delays and market competition, but expansion and capital discipline continue.

6 weeks ago - Transcripts

Specialized Medical Company Earnings Call Transcript: Q3 2025

Q3 2025 saw strong revenue and profit growth, driven by a strategic shift to acute and outpatient services, with EBITDA margin rising to 27.3%. Expansion continues with new clinics and hospitals, a SAR 200 million special dividend, and robust guidance for year-end.

6 months ago - Transcripts